Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check6 days agoChange DetectedThe page shows an updated revision version from v3.6.5 to v3.6.6, indicating a small internal update. This update does not modify the study details, eligibility criteria, or other user-visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's metadata. This update does not alter study information or visible content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe website shows a revision update to v3.6.4, replacing the previous v3.6.3; this signals a backend update rather than changes to the study information presented.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3. This reflects a new document version shown in the page footer.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page footer now displays the revision label v3.6.2, replacing the previous v3.6.0. This is a minor site maintenance update with no changes to content or functionality.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page adds a recruitment status indicator ('No longer looking for participants') and new user-help sections such as 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and 'Intervention/Treatment'. It also replaces the label 'Intervention / Treatment' with the unified 'Intervention/Treatment' heading.SummaryDifference0.4%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.